Snowball logo
logo
PTGX_logo

Protagonist Therapeutics Inc

PTGX NASDAQ
$104.72+$7.15  (7.33%)

Frequently asked questions

What sector does Protagonist Therapeutics Inc (PTGX) operate in?

Protagonist Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Protagonist Therapeutics Inc (PTGX) current stock price?

As of the latest data, Protagonist Therapeutics Inc stock price is $104.72, with a previous close of $97.57. Protagonist Therapeutics Inc gained $7.15 in the last trading session, representing a 7.33% increase.

What is Protagonist Therapeutics Inc (PTGX) current market capitalization?

Protagonist Therapeutics Inc market cap is approximately 6.68 billion.

What is Protagonist Therapeutics Inc (PTGX) Earnings Per Share (EPS)?

The trailing EPS is -$2.05, and the forward EPS is -$0.58.

What is Protagonist Therapeutics Inc (PTGX) EBITDA?

Protagonist Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -43.34 million.

Does Protagonist Therapeutics Inc (PTGX) pay dividends?

No. Protagonist Therapeutics Inc does not pay a dividend.

How did Protagonist Therapeutics Inc (PTGX) perform in its most recent earnings report?

In the last report (December 31, 2025), Protagonist Therapeutics Inc posted an EPS surprise of -102.76% and a revenue surprise of -85.27%.

When is Protagonist Therapeutics Inc (PTGX) next earnings report?

Protagonist Therapeutics Inc is expected to release its next earnings report on March 31, 2026.

What is Protagonist Therapeutics Inc (PTGX) beta (volatility) score?

Protagonist Therapeutics Inc has a beta of 2.239, indicating very high volatility compared to the market.